ARCHIVES

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

Hollings Cancer Center at MUSC Wins NCI Designation

March 6, 2009

NCI Seeks CRADA Partners To Develop Targets Drugs

October 24, 1997

Bernard Fisher Sues Univ. of Pittsburgh And Its Attorney

July 15, 1994

Politics May Play Role In FDA’s Avastin Decision

May 27, 2011

DCT Board Approves New Task Orders For RMP Clinical Trials, Holds Up On Additional Grants

February 20, 1981

NCI to Study Review Group’s report Urging Restructure of Prevention Programm

June 27, 1997